Okomera

Okomera is developing a desktop platform for automated organoid screening using droplet-microfluidics and AI to accelerate drug discovery in oncology. Their patented technology, developed after 10 years of research, provides multiplexing, co-culture, and high-throughput screening of drug candidates on miniaturized Patient Derived Organoids (PDOs). This platform aims to improve the accuracy of disease models and the identification of new therapeutic targets.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount:

Date: 21-Oct-2024

Investors: Bpifrance

Markets: Oncology, Drug Discovery, Biotechnology, Life Science, Therapeutics

HQ: Paris, Île-de-France, France

Founded: 2020

Website: https://www.okomera.com/

LinkedIn: https://www.linkedin.com/company/okomera

Twitter: https://twitter.com/Okomera1

Instagram: